Commercialisation of biotechnology research.

	Fax	(03) 9613 4111
	Principal Sector	Health & Pharm
	Principal Industry	Biotechnology
	Listed	2004/01/28
	Homepage	www.biodiem.com/

Stock Exchange Stock Code   ASX:BDM BDM ZOBEX A6P

BioDiem To Commence Diabetic Blindness Trial with BDM-E Treatment (DEC 2, 2005)

BioDiem receives milestone payment of US$1m for Flu Vaccine from Nobilon (NOV 29, 2005)

Biodiem Limited ASX: BDM - 2007 Annual General Meeting Summary - Dr Andrew O'Brien, Managing Director (NOV 30, 2007)

Biodiem Limited ASX: BDM - FY07 Results And Commencement Of 4 New Monash Studies For Eye Drug BMD-E - Mr Tom Williams, MD (AUG 31, 2007)

Biodiem Limited ASX: BDM - Completes Treatment Phase I And II Study Of Eye Drug - Mr Tom Williams, MD (AUG 13, 2007)